Clinical trials
Recruiting Phase 2/3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Pharmaceuticals Holding Co., Ltd | 2 |
| Bristol-Myers Squibb | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Guangdong Provincial People's Hospital | 1 |
| M.D. Anderson Cancer Center | 1 |
| Peking Union Medical College Hospital | 1 |
| Second Affiliated Hospital of Guangzhou Medical University | 1 |
| Shanghai Henlius Biotech | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 13 |
| Head and Neck Neoplasms | 2 |
| Melanoma | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Colonic Neoplasms | 1 |
| Kidney Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.